Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
58%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
OZEM
22
HOLDINGS
59%
ALSO IN THNR
THNR
17
HOLDINGS
76%
ALSO IN OZEM
SECTOR DRIFT (OZEM minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in OZEM |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
NOVO-NORDISK A/S-SPONS ADR | 14.5% | 13.5% | 13.5% |
 |
ELI LILLY & CO | 15.3% | 11.3% | 11.3% |
 |
INNOVENT BIOLOGICS, INC. | 5.1% | 5.3% | 5.1% |
|
PFIZER INC | 7.2% | 4.9% | 4.9% |
|
AMGEN INC | 3.8% | 6.2% | 3.8% |
OZEM Overweight Relative to THNR
 |
ASCLETIS PHARMA, INC. | 5.3% |
|
ELI LILLY & CO | 4.0% |
|
SHANGHAI FOSUN PHARMACEUTI-H | 3.3% |
|
VIKING THERAPEUTICS, INC. | 3.0% |
 |
HANMI PHARM CO LTD | 2.3% |
 |
THE UNITED LABORATORIES INTE | 2.3% |
|
PFIZER INC | 2.2% |
|
MBX BIOSCIENCES INC | 2.1% |
|
ZEALAND PHARMA A/S | 1.9% |
|
GILEAD SCIENCES INC | 1.8% |
OZEM Underweight Relative to THNR
|
ARROWHEAD PHARMACEUTICALS, INC. | -5.8% |
|
MERCK & CO. INC. | -4.7% |
|
ABBVIE INC | -4.3% |
|
REGENERON PHARMACEUTICALS | -3.5% |
 |
SHIONOGI & CO LTD | -3.1% |
|
CHUGAI PHARMACEUTICAL CO LTD | -2.6% |
|
AMGEN INC | -2.4% |
|
SCHOLAR ROCK HOLDING CORP. | -2.2% |
|
CHINA PHARMACEUTICAL GROUP | -2.1% |
 |
ASTRAZENECA PLC | -1.3% |